Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants-Reference-Cited by-同舟云学术

Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants

Published:2022-04-01 Issue:4 Volume:158 Page:366
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Mosallaei Daniel¹,Hao Michelle¹,Antaya Richard J.²,Levian Brandon¹,Kwong Andrew¹,Cogan Jon¹,Hamilton Claire²,Schwieger-Briel Agnes³,Tan Calvin¹,Tang Xin¹,Woodley David T.¹,Chen Mei¹

Affiliation:

1. Department of Dermatology, The Keck School of Medicine, University of Southern California, Los Angeles

2. Department of Dermatology and Pediatrics, Yale School of Medicine, New Haven, Connecticut

3. Pediatric Skin Center, Division of Pediatric Dermatology, University Children’s Hospital Zurich, Zurich, Switzerland

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2789287/jamadermatology_mosallaei_2022_oi_210075_1649281902.20832.pdf

Reference40 articles.

1. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.;Has;Br J Dermatol,2020

2. Herlitz junctional epidermolysis bullosa.;Laimer;Dermatol Clin,2010

3. Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.;Mühle;Hum Genet,2005

4. Burden of itch in epidermolysis bullosa.;Snauwaert;Br J Dermatol,2014

5. Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011.;Kelly-Mancuso;Pediatr Dermatol,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LAMB3: Central role and clinical significance in neoplastic and non-neoplastic diseases;Biomedicine & Pharmacotherapy;2024-09

2. Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules;Nature Genetics;2024-08-22

3. Treatment of Epidermolysis Bullosa and Future Directions: A Review;Dermatology and Therapy;2024-08

4. Epidermolysis Bullosa: A Review of Wound Care and Emerging Treatments;Current Dermatology Reports;2024-07-30

5. Systematic review on antipruritic therapies for patients with Epidermolysis bullosa;Journal of Dermatological Treatment;2024-07-28